The 11th in a series of 12 monthly webinars on medication assisted treatments (MAT) in primary care settings created by the California Society of Addiction Medicine with the support of a grant from the California Health Care Foundation. No Pharma money was used in creating this series.
Case-based webinar will address patients with chronic non-cancer pain who have been maintained on high dose opioids (> 90-250MED) for months years without improvement in functional outcome and break out characteristics of what is increasingly being called the "Lost Generation:" patients taking in excess of 240 MED. The speaker will present one clinician's approach to these patients including the clinical importance of withdrawal and harm reduction strategies such as naloxone kits, supporting patients through tapering, if tapers fail, transitioning to buprenorphine from higher dose opioids to improve safety in high-risk cohort.
Learning Objectives After attending this participants will be able to:
- Identify patients at a high risk for an unintentional opioid over-dose
- Describe harm reduction strategies including: co-prescribing nasal naloxone, opioid taper strategies, and rotation to buprenorphine in the face of a 'failed' opioid taper
- Acquire language to talk about the process of the opioid taper with vulnerable patients
Credit: This live internet activity is jointly provided by the California Society of Addiction Medicine (CSAM) and the California Health Care Foundation. CSAM is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™ Physicians should only claim credit commensurate with the extent of their participation in the activity.
PA’s, nurses, pharmacists, psychologists and therapists can earn CEU credit.